COVID-19 Session: Anticoagulation, VTE Burden and Resources
Anticoagulation Management During the Pandemic
A quality improvement project found risk stratified warfarin monitoring with expanded home point of care testing preserved therapeutic range and reduced bleeding while cutting visits, and a trial found early outpatient sulodexide reduced hospitalization and oxygen support without changing mortality.
VTE Burden in Hospitalized COVID-19 Patients
A Mayo Clinic matched cohort study found hospitalized COVID-19 patients had roughly an eighteen fold higher odds of DVT or PE than matched controls, with DVT or PE independently predicting higher mortality, more ICU admissions, and longer hospital stays.
Vascular Lab Triage to Preserve PPE
A physician review protocol requiring justification for vascular lab requests cut testing volume by half without missing pathology needing changed management, reducing staff exposure risk and personal protective equipment use during a period of critical shortage.
Case Report: Iliocaval Thrombosis and May-Thurner Syndrome
A COVID-19 patient with mild respiratory symptoms presented with extensive left iliocaval thrombus revealing underlying May-Thurner syndrome, treated successfully with mechanical thrombectomy, catheter thrombolysis, and iliac vein stenting with an IVC filter later retrieved.
